John M. Errico
0000-0002-4452-8152
Publication & Citation Trends
Publications
0 total
Potent efficacy of an NA-targeting antibody against a broad spectrum of H5N1 influenza viruses.
Cited by 0
Semantic Scholar
Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells.
Cited by 6
Semantic Scholar
The engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor positive cells leading to activation of HBV-specific T cells OA
Cited by 0
Semantic Scholar
A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification OA
Cited by 35
Semantic Scholar
Vertebrate-class-specific binding modes of the alphavirus receptor MXRA8.
Cited by 32
Semantic Scholar
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies OA
Cited by 398
Semantic Scholar
Antibody-mediated immunity to SARS-CoV-2 spike OA
Cited by 16
Semantic Scholar
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains OA
Cited by 138
Semantic Scholar
Research Topics
SARS-CoV-2 and COVID-19 Research
(18)
Mosquito-borne diseases and control
(8)
Viral gastroenteritis research and epidemiology
(8)
SARS-CoV-2 detection and testing
(7)
COVID-19 Clinical Research Studies
(6)
Affiliations
Google (United States)
Harvard University
University of California, Santa Barbara
Carnegie Institution for Science
University of Zurich